Worries that tumor necrosis factor (TNF) inhibitors may exacerbate or even cause lung disease in patients with rheumatoid ...
The U.S. Court of Appeals for the Federal Circuit (CAFC) today issued a precedential decision reversing a district court’s ...
Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.
The Federal Circuit reversed a Delaware district court’s 2023 ruling axing a Novartis Pharmaceuticals Corp. patent covering ...
Can science prevail against this more turbulent backdrop of the Trump administration? Yahoo Finance executive editor Brian ...
Marea’s Phase IIa study enrolled patients with hypertriglyceridemia—too much fat in the blood. The latest results showed the ...
Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...
Initial clinical data from Phase 1 SAD/MAD study of VAV1-directed molecular glue degrader (MGD) MRT-6160 expected in Q1 2025Additional clinical ...
New Directors Bring Extensive Leadership Experience in Corporate Strategy and Commercialization. SEATTLE and VANCOUVER, ...
Dr. Buchanan will helm Belharra’s research organization as the company progresses its lead immunology and oncology programs, advances activities ...
Survivors of childhood cancer face challenges from bone mineral density (BMD) deficits due to treatment exposures and other ...
Middle East and Asia Injectable Drugs market 2025 To achieve a therapeutic effect in humans and animals, drug delivery is the method of delivering a Pharmaceutical compound. Mr. Shah Coherent Market ...